Local and state paid sick leave policies and timeliness of treatment initiation among working-age patients with early-stage breast cancer.

K Kewei Sylvia Shi (American Cancer Society, Atlanta, GA) Q Qinjin Fan (American Cancer Society, Atlanta, GA) J Justin Michael Barnes (Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ) F Fumiko Chino (The University of Texas MD Anderson Cancer Center, Houston, TX) C Cathy J. Bradley (Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO) Y Ya-Chen Tina Shih X Xin Hu J Jingxuan Zhao Z Zhiyuan Zheng (School of Chemistry and Chemical Engineering) X Xuesong Han R Robin Yabroff (American Cancer Society, Atlanta, GA)

Abstract

11064 Background: Local and state paid sick leave (PSL) mandates have been associated with increased use of preventive services, including cancer screening, and reduced emergency care utilization. Little research has examined PSL policies and cancer after diagnosis. This study evaluates associations of PSL policies and timely treatment initiation among women with early-stage breast cancer. Methods: We identified patients aged 18-64 years newly diagnosed with stages 0-II breast cancer from the National Cancer Database in 2004-2023 and linked then to area-level policy implementation, measured as the month and year the state, county, or city required PSL. Primary outcomes were receipt of definitive surgery or neoadjuvant therapy within 30, 60, and 90 days of diagnosis. We compared changes in treatment initiation between patients residing in areas with and without PSL policies during and after the month and year of diagnosis. We used a staggered difference-in-differences design to account for differential timing of implementation, adjusting for patient demographics, clinical, and area-level characteristics. Random errors were clustered at the state level. Supplemental analyses stratified by county-level unemployment rates and individual insurance coverage. Results: The study included 1,891,411 patients, of whom 249,313 (13.2%) resided in an area with PSL policies at diagnosis. Patients in areas with PSL policies were more likely to have Medicaid, reside in higher-income and metropolitan areas. PSL policy implementation was significantly associated with a 3.4 percentage point (PPT) increase in the probability of treatment ≤30 days (95% CI: 1.1-5.7), 3.0 PPT increase ≤60 days (95% CI: 1.6-4.3), 1.3 PPT increase ≤90 days (95% CI: 0.5-2.1) (Table). Improvements in timely treatment were concentrated in low-unemployment areas; no significant improvements were observed in high-unemployment areas. The magnitude of associations between PSL policies and treatment initiation was stronger among patients without private insurance than with private insurance. Conclusions: Local and state PSL mandates were associated with earlier treatment initiation among working-age patients with early-stage breast cancer, especially in areas with low female unemployment rate. Findings suggest that PSL policies play an important role in timely cancer treatment for employed women who may not have PSL through their jobs. Association of paid sick leave policies and breast cancer treatment initiation. Time from diagnosis to surgery/neoadjuvant therapy (days) DID PPT Lower 95% CI Upper 95% CI P-value Overall ≤30 3.4 1.1 5.7 0.004 ≤60 3.0 1.6 4.3 0.000 ≤90 1.3 0.5 2.1 0.001 Low female unemployment ≤30 2.2 -0.7 5.0 0.136 ≤60 3.8 1.8 5.8 0.000 ≤90 1.2 0.3 2.2 0.012 High female unemployment ≤30 1.8 -0.6 4.2 0.145 ≤60 -1.2 -4.5 2.0 0.459 ≤90 -1.4 -3.7 0.9 0.232

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
Pages 11064-11064
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (11)

K

Kewei Sylvia Shi

American Cancer Society, Atlanta, GA

Q

Qinjin Fan

American Cancer Society, Atlanta, GA

J

Justin Michael Barnes

Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ

F

Fumiko Chino

The University of Texas MD Anderson Cancer Center, Houston, TX

C

Cathy J. Bradley

Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO

Y

Ya-Chen Tina Shih

X

Xin Hu

J

Jingxuan Zhao

Z

Zhiyuan Zheng

School of Chemistry and Chemical Engineering

X

Xuesong Han

R

Robin Yabroff

American Cancer Society, Atlanta, GA